Scientists identify RPS-12 protein as a potential target for anti-cancer therapy
Children prioritize what they hear over what they see when gauging emotional aspects of their experience
29 January 2021Another deadly disease for smokers: Pulmonary fibrosis
29 January 2021Scientists identify RPS-12 protein as a potential target for anti-cancer therapy
Using the developing eye of the fruit fly as a test platform, researchers found that RPS-12 protein overproduction appears to trigger triple-negative breast cancer and possibly some other malignancies. The protein indirectly switches on an important intracellular signaling pathway active while the embryo develops, but which shuts down in healthy cells of adults. Far Eastern Federal University (FEFU), the University of Geneva, and the Institute of Protein Research (Russia) scientists describe the problem in Scientific Reports.
